{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-051382","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.222062+00:00","generated_at":"2026-05-16T20:59:08.900994+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Precision BioSciences prices $75M underwritten offering of common stock and warrants","bullets":["Offering: 10.8M shares + 1.4M pre-funded warrants at $6.14/$6.139995 per unit; gross proceeds ~$75M.","Net proceeds ~$70M after discounts and expenses, expected close Nov 12, 2025.","Each whole warrant exercises at $7.25/share, 5-year term; 4.99% beneficial ownership cap applies.","Proceeds to fund R&D for ARCUS gene editing pipeline and working capital.","Guggenheim Securities sole book-runner; participation from Aberdeen, Bleichroeder, Driehaus, and others."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-051382","json":"https://secwatch.observer/filing/0001628280-25-051382.json","markdown":"https://secwatch.observer/filing/0001628280-25-051382.md","text":"https://secwatch.observer/filing/0001628280-25-051382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/0001628280-25-051382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/dtil-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:59:08.900994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}